PUBLISHER: TechSci Research | PRODUCT CODE: 1738322
PUBLISHER: TechSci Research | PRODUCT CODE: 1738322
Maternal Mental Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Indication, By Therapy, By Region & Competition, 2020-2030F
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Maternal Mental Health Market was valued at USD 5.83 billion in 2024 and is projected to reach new growth levels by 2030, expanding at a CAGR of 9.23%. Maternal mental health, encompassing conditions such as postpartum depression, anxiety, and PTSD, is increasingly recognized as a public health priority. These mental health challenges can arise during pregnancy or the postpartum period and have serious implications for both mother and child, including premature birth and developmental issues. Rising awareness, the normalization of seeking help, and improved access to mental healthcare services are contributing to the market's growth. Additionally, healthcare providers and policy makers are implementing more comprehensive screening and treatment strategies. Technological advancements, including mobile health apps, wearable monitoring devices, and AI-powered analytics, are also playing a pivotal role in early detection and personalized intervention. The increasing global birth rate, coupled with heightened awareness and support infrastructure, is expected to fuel robust growth in the maternal mental health market over the coming years.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 5.83 Billion |
| Market Size 2030 | USD 9.82 Billion |
| CAGR 2025-2030 | 9.23% |
| Fastest Growing Segment | Antidepressants |
| Largest Market | North America |
Key Market Drivers
High Prevalence of Maternal Mental Health Disorders is Driving Global Maternal Mental Health Market
The increasing recognition of the prevalence and impact of perinatal mental health disorders is a primary driver for the market. Conditions such as postpartum depression, general anxiety, and PTSD are now known to affect a substantial proportion of women during and after pregnancy. Studies indicate that up to one in seven women in the U.S. experience postpartum depression, with other regions reflecting similarly high rates. The COVID-19 pandemic further intensified maternal mental health concerns, with research from the University of Michigan highlighting that nearly one in three mothers during early 2020 experienced symptoms of depression. This growing awareness has encouraged greater demand for mental health services tailored specifically to the maternal population. Healthcare systems, non-profits, and governments are increasingly supporting maternal mental health programs, while tech firms and pharmaceutical companies are innovating around treatment and support tools, further driving market expansion.
Key Market Challenges
Stigma and Awareness
One of the major obstacles hindering market growth is the persistent stigma surrounding mental health during and after pregnancy. Many women feel pressured to conform to societal expectations that motherhood should be a purely joyful experience, leading to feelings of guilt or fear of judgment if they disclose emotional distress. As a result, many mothers delay or avoid seeking treatment altogether. Compounding this issue is the lack of consistent mental health screening in prenatal and postpartum care. To combat these barriers, efforts must focus on awareness campaigns, caregiver training, and integration of mental health checks into routine maternal care. Destigmatizing maternal mental health through education and supportive community platforms remains essential to unlocking further growth in the market.
Key Market Trends
Technological Advancements
Technology is playing a transformative role in the maternal mental health market. The rise of telehealth has made it easier for women to access care from the safety and privacy of their homes. Mobile apps designed for mood tracking, meditation, and personalized support are becoming more prevalent, offering scalable and accessible mental health solutions. Wearable technologies also support continuous monitoring of vital signs and stress indicators, enabling early detection of mental distress. Artificial Intelligence is being used to analyze behavioral and physiological data, helping predict mental health risks and guide timely interventions. Moreover, Virtual Reality is emerging as a therapeutic tool for treating postpartum anxiety and PTSD by offering immersive relaxation and exposure therapy experiences. Collectively, these technological developments are helping to reduce barriers to care, improve treatment personalization, and enhance patient engagement.
Key Market Players
- Therapy Mama
- Canopie
- Pfizer Inc
- Viatris Inc.
- GlaxoSmithKline Inc.
- Alembic Pharmaceuticals Limited
- Mallinckrodt Inc.
- Sage Therapeutics, Inc.
- Bausch Health Companies Inc.
- Magellan Health, Inc.
Report Scope:
In this report, the Global Maternal Mental Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Maternal Mental Health Market, By Disease Indication:
- Postpartum Depression
- Dysthymia
- Pregnancy and Postpartum General Anxiety
- Pregnancy and Postpartum OCD
- Birth-Related PTSD
- Others
Maternal Mental Health Market, By Therapy:
- Interpersonal Psychotherapy
- Antidepressants
- Cognitive Behavioral Therapy
- Others
Maternal Mental Health Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Maternal Mental Health Market.
Available Customizations:
Global Maternal Mental Health market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
4. Voice of Customer
5. Global Maternal Mental Health Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others)
- 5.2.2. By Therapy (Interpersonal Psychotherapy, Antidepressants, Cognitive Behavioral Therapy, others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
- 5.3. Market Map
6. North America Maternal Mental Health Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Disease Indication
- 6.2.2. By Therapy
- 6.2.3. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Maternal Mental Health Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Disease Indication
- 6.3.1.2.2. By Therapy
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Maternal Mental Health Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Disease Indication
- 6.3.2.2.2. By Therapy
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Maternal Mental Health Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Disease Indication
- 6.3.3.2.2. By Therapy
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Maternal Mental Health Market Outlook
7. Europe Maternal Mental Health Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Disease Indication
- 7.2.2. By Therapy
- 7.2.3. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Maternal Mental Health Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Disease Indication
- 7.3.1.2.2. By Therapy
- 7.3.1.1. Market Size & Forecast
- 7.3.2. United Kingdom Maternal Mental Health Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Disease Indication
- 7.3.2.2.2. By Therapy
- 7.3.2.1. Market Size & Forecast
- 7.3.3. Italy Maternal Mental Health Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecasty
- 7.3.3.2.1. By Disease Indication
- 7.3.3.2.2. By Therapy
- 7.3.3.1. Market Size & Forecast
- 7.3.4. France Maternal Mental Health Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Disease Indication
- 7.3.4.2.2. By Therapy
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Maternal Mental Health Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Disease Indication
- 7.3.5.2.2. By Therapy
- 7.3.5.1. Market Size & Forecast
- 7.3.1. Germany Maternal Mental Health Market Outlook
8. Asia-Pacific Maternal Mental Health Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Disease Indication
- 8.2.2. By Therapy
- 8.2.3. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Maternal Mental Health Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Disease Indication
- 8.3.1.2.2. By Therapy
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Maternal Mental Health Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Disease Indication
- 8.3.2.2.2. By Therapy
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Maternal Mental Health Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Disease Indication
- 8.3.3.2.2. By Therapy
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Maternal Mental Health Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Disease Indication
- 8.3.4.2.2. By Therapy
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Maternal Mental Health Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Disease Indication
- 8.3.5.2.2. By Therapy
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Maternal Mental Health Market Outlook
9. South America Maternal Mental Health Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Disease Indication
- 9.2.2. By Therapy
- 9.2.3. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Maternal Mental Health Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Disease Indication
- 9.3.1.2.2. By Therapy
- 9.3.1.1. Market Size & Forecast
- 9.3.2. Argentina Maternal Mental Health Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Disease Indication
- 9.3.2.2.2. By Therapy
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Colombia Maternal Mental Health Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Disease Indication
- 9.3.3.2.2. By Therapy
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Brazil Maternal Mental Health Market Outlook
10. Middle East and Africa Maternal Mental Health Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Disease Indication
- 10.2.2. By Therapy
- 10.2.3. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Maternal Mental Health Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Disease Indication
- 10.3.1.2.2. By Therapy
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Saudi Arabia Maternal Mental Health Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Disease Indication
- 10.3.2.2.2. By Therapy
- 10.3.2.1. Market Size & Forecast
- 10.3.3. UAE Maternal Mental Health Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Disease Indication
- 10.3.3.2.2. By Therapy
- 10.3.3.1. Market Size & Forecast
- 10.3.1. South Africa Maternal Mental Health Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition
- 12.2. Product Development
- 12.3. Recent Developments
13. Global Maternal Mental Health Market: SWOT Analysis
14. Competitive Landscape
- 14.1. Therapy Mama
- 14.1.1. Business Overview
- 14.1.2. Application Offerings
- 14.1.3. Recent Developments
- 14.1.4. Key Personnel
- 14.1.5. SWOT Analysis
- 14.2. Canopie
- 14.3. Pfizer Inc
- 14.4. Viatris Inc.
- 14.5. GlaxoSmithKline Inc.
- 14.6. Alembic Pharmaceuticals Limited
- 14.7. Mallinckrodt Inc.
- 14.8. Sage Therapeutics, Inc.
- 14.9. Bausch Health Companies Inc.
- 14.10. Magellan Health, Inc.
15. Strategic Recommendations
16. About Us & Disclaimer
